Document is current
Any future updates will be listed below
-
Authors
Kang, Hana
Kim, Ok-Hyeon
Chang, Eun Seo
Kim, Jinho
Kim, Ji-Young
Shin, Geun-Seup
Kim, Chul-Hong
Lim, Younghyun
Seo, Young-Jin
Kim, Jung-Woong
Lee, Hyun Jung https://orcid.org/0000-0002-9941-9826
-
Funding
Funding for this research was provided by:
Ministry of Education (2023R1A2C2006894, RS-2024-00409554, RS-2023-00220089, 2023R1A2C1007657, RS-2024-00361192)
- License Information
-
More Information
Article History
Received: 19 March 2025
Accepted: 26 May 2025
First Online: 3 June 2025
Declarations
:
: The study was reviewed and approved by the IACUC of Chung-Ang University (Approval ID: 202301020051) as follows; (1) Title of the approved project: Validation of septic shock treatment with preconditioned MSCs (2) Name of the institutional approval committee: IACUC of Chung-Ang University (3) Approval number: 202301020051 (4) Date of approval: June 21, 2023. Human MSCs were purchased from AllCells, which has confirmed that the initial collection of the cells was conducted with ethical approval and that informed consent was obtained from all donors. The human THP-1 cell line was purchased from the Korean Cell Line Bank and was originally established in 1980. We have cited the original publication and submitted the certificate of analysis (COA) for reference.
: Not applicable.
: The authors have declared that they have no competing interests.
